p-Menth-1-en-3-ol

Details

Top
Internal ID ef8aa9c0-5fed-4633-ac00-f9742ac65a02
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Menthane monoterpenoids
IUPAC Name 3-methyl-6-propan-2-ylcyclohex-2-en-1-ol
SMILES (Canonical) CC1=CC(C(CC1)C(C)C)O
SMILES (Isomeric) CC1=CC(C(CC1)C(C)C)O
InChI InChI=1S/C10H18O/c1-7(2)9-5-4-8(3)6-10(9)11/h6-7,9-11H,4-5H2,1-3H3
InChI Key HPOHAUWWDDPHRS-UHFFFAOYSA-N
Popularity 70 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H18O
Molecular Weight 154.25 g/mol
Exact Mass 154.135765193 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 2.10
Atomic LogP (AlogP) 2.36
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
491-04-3
3-Carvomenthenol
2-Cyclohexen-1-ol, 3-methyl-6-(1-methylethyl)-
6-(Isopropyl)-3-methylcyclohex-2-en-1-ol
3-methyl-6-propan-2-ylcyclohex-2-en-1-ol
Piperitol (monoterpene)
UNII-7UM0ILT6I7
1-Methyl-4-isopropyl-1-cyclohexen-3-ol
FEMA No. 3179
11063-75-5
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of p-Menth-1-en-3-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9932 99.32%
Caco-2 + 0.8140 81.40%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5857 58.57%
Subcellular localzation Mitochondria 0.4533 45.33%
OATP2B1 inhibitior - 0.8516 85.16%
OATP1B1 inhibitior + 0.9587 95.87%
OATP1B3 inhibitior + 0.9240 92.40%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior - 0.9375 93.75%
P-glycoprotein inhibitior - 0.9755 97.55%
P-glycoprotein substrate - 0.9498 94.98%
CYP3A4 substrate - 0.6420 64.20%
CYP2C9 substrate - 0.8090 80.90%
CYP2D6 substrate - 0.7021 70.21%
CYP3A4 inhibition - 0.8710 87.10%
CYP2C9 inhibition - 0.7853 78.53%
CYP2C19 inhibition - 0.7887 78.87%
CYP2D6 inhibition - 0.8693 86.93%
CYP1A2 inhibition - 0.6591 65.91%
CYP2C8 inhibition - 0.9837 98.37%
CYP inhibitory promiscuity - 0.6579 65.79%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.7928 79.28%
Carcinogenicity (trinary) Non-required 0.6124 61.24%
Eye corrosion - 0.8028 80.28%
Eye irritation + 0.8003 80.03%
Skin irritation + 0.8004 80.04%
Skin corrosion - 0.5990 59.90%
Ames mutagenesis - 0.8100 81.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5673 56.73%
Micronuclear - 0.9800 98.00%
Hepatotoxicity - 0.5750 57.50%
skin sensitisation + 0.8348 83.48%
Respiratory toxicity - 0.6333 63.33%
Reproductive toxicity - 0.5667 56.67%
Mitochondrial toxicity - 0.7625 76.25%
Nephrotoxicity - 0.6693 66.93%
Acute Oral Toxicity (c) III 0.7298 72.98%
Estrogen receptor binding - 0.9683 96.83%
Androgen receptor binding - 0.7751 77.51%
Thyroid receptor binding - 0.8743 87.43%
Glucocorticoid receptor binding - 0.8882 88.82%
Aromatase binding - 0.9479 94.79%
PPAR gamma - 0.9162 91.62%
Honey bee toxicity - 0.9583 95.83%
Biodegradation + 0.5250 52.50%
Crustacea aquatic toxicity - 0.5300 53.00%
Fish aquatic toxicity + 0.9570 95.70%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.69% 96.09%
CHEMBL2581 P07339 Cathepsin D 90.04% 98.95%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.28% 100.00%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.10% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.27% 95.56%
CHEMBL3137262 O60341 LSD1/CoREST complex 82.89% 97.09%
CHEMBL5608 Q16288 NT-3 growth factor receptor 82.50% 95.89%
CHEMBL1871 P10275 Androgen Receptor 80.79% 96.43%
CHEMBL3359 P21462 Formyl peptide receptor 1 80.66% 93.56%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 80.57% 95.89%
CHEMBL1907594 P30926 Neuronal acetylcholine receptor; alpha3/beta4 80.32% 97.23%

Cross-Links

Top
PubChem 10282
NPASS NPC207561
LOTUS LTS0261305
wikiData Q81984934